01 1Gowling Lafleur Henderson LLP
02 1Gowling WLG (Canada) LLP
01 22478169
01 2RAMUCIRUMAB
01 2SOLUTION
01 22023-03-04
Patent Expiration Date : 2023-03-04
Date Granted : 2013-04-16
Brand Name : CYRAMZA
Patent Number : 2478169
Filing Date : 2003-03-04
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2023-03-04
Date Granted : 2013-04-16
Patent Expiration Date : 2023-03-04
Date Granted : 2013-04-16
Brand Name : CYRAMZA
Patent Number : 2478169
Filing Date : 2003-03-04
Strength per Unit : 10 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2023-03-04
Date Granted : 2013-04-16
